While tumours of all genotypes were predominantly low-grade adenocarcinomas, the proportion of tumours that progressed to high-grade adenocarcinomas was relatively higher in WT mice compared to their myeloid-ILK deficient counterparts (Figure 1F), suggesting a role for myeloid-ILK in tumour progression. This evidence concerns the gene ILK and adenocarcinoma.